Medinova Diagnostic Services Ltd
Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.
- Market Cap ₹ 37.6 Cr.
- Current Price ₹ 37.6
- High / Low ₹ 51.0 / 30.7
- Stock P/E 19.8
- Book Value ₹ -2.20
- Dividend Yield 0.00 %
- ROCE 232 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 2.54% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.00 | 7.47 | 7.79 | 8.67 | 8.97 | 7.45 | 12.74 | 13.20 | 9.99 | 10.17 | 9.79 | |
| 10.28 | 7.49 | 7.68 | 7.94 | 7.64 | 6.25 | 9.74 | 9.45 | 7.34 | 7.34 | 6.89 | |
| Operating Profit | -3.28 | -0.02 | 0.11 | 0.73 | 1.33 | 1.20 | 3.00 | 3.75 | 2.65 | 2.83 | 2.90 |
| OPM % | -46.86% | -0.27% | 1.41% | 8.42% | 14.83% | 16.11% | 23.55% | 28.41% | 26.53% | 27.83% | 29.62% |
| 0.33 | 0.17 | 1.77 | 1.48 | 1.70 | 0.07 | 0.14 | 0.15 | 0.23 | 0.20 | 0.21 | |
| Interest | 0.23 | 0.52 | 1.06 | 0.84 | 0.66 | 0.59 | 0.46 | 0.56 | 0.65 | 0.62 | 0.52 |
| Depreciation | 1.03 | 1.92 | 2.66 | 1.88 | 1.29 | 0.95 | 0.72 | 0.55 | 0.33 | 0.13 | 0.14 |
| Profit before tax | -4.21 | -2.29 | -1.84 | -0.51 | 1.08 | -0.27 | 1.96 | 2.79 | 1.90 | 2.28 | 2.45 |
| Tax % | -14.73% | -9.61% | -5.43% | -11.76% | 25.00% | -18.52% | 3.06% | 15.05% | 12.11% | 12.28% | |
| -3.59 | -2.07 | -1.74 | -0.45 | 0.82 | -0.23 | 1.90 | 2.38 | 1.67 | 2.00 | 1.90 | |
| EPS in Rs | -3.79 | -2.00 | -1.74 | -0.45 | 0.82 | -0.26 | 2.02 | 2.27 | 1.67 | 2.00 | 1.90 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | -7% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 2% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 20% |
| 3 Years: | -2% |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.46 | 9.46 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 |
| Reserves | -16.24 | -18.14 | -19.52 | -19.66 | -18.87 | -19.13 | -17.15 | -16.77 | -15.09 | -13.08 | -12.16 |
| 1.89 | 8.90 | 8.45 | 7.26 | 6.43 | 5.64 | 4.47 | 6.38 | 5.75 | 5.00 | 5.00 | |
| 15.27 | 12.59 | 9.70 | 8.51 | 7.25 | 7.59 | 7.10 | 4.87 | 3.86 | 3.50 | 3.58 | |
| Total Liabilities | 10.38 | 12.81 | 8.59 | 6.07 | 4.77 | 4.06 | 4.38 | 4.44 | 4.48 | 5.38 | 6.38 |
| 6.54 | 9.24 | 6.89 | 4.48 | 3.34 | 2.40 | 1.87 | 1.49 | 1.55 | 1.64 | 1.91 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 3.84 | 3.57 | 1.70 | 1.59 | 1.43 | 1.66 | 2.51 | 2.95 | 2.93 | 3.74 | 4.47 | |
| Total Assets | 10.38 | 12.81 | 8.59 | 6.07 | 4.77 | 4.06 | 4.38 | 4.44 | 4.48 | 5.38 | 6.38 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.62 | 0.08 | 1.16 | 1.30 | 1.24 | 1.69 | 1.35 | 1.42 | 2.67 | ||
| -4.65 | -0.11 | 0.37 | -0.15 | -0.16 | -0.06 | -1.84 | -0.34 | -0.21 | ||
| 5.33 | -0.01 | -1.50 | -1.20 | -1.07 | -1.37 | 0.31 | -0.85 | -1.32 | ||
| Net Cash Flow | 0.06 | -0.04 | 0.04 | -0.06 | 0.01 | 0.25 | -0.17 | 0.23 | 1.14 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37.54 | 22.48 | 14.53 | 8.84 | 19.12 | 17.15 | 23.78 | 14.38 | 25.58 | 15.43 |
| Inventory Days | 86.45 | 58.99 | 32.30 | |||||||
| Days Payable | 3,462.70 | 1,533.74 | 1,353.41 | |||||||
| Cash Conversion Cycle | -3,338.71 | -1,452.27 | -1,306.58 | 8.84 | 19.12 | 17.15 | 23.78 | 14.38 | 25.58 | 15.43 |
| Working Capital Days | -618.94 | -543.35 | -453.56 | -369.21 | -262.05 | -342.46 | -164.16 | -105.35 | -97.92 | -92.95 |
| ROCE % | 2,684.21% | 232.00% |
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('Listing Regulations')
6 Feb - Disclosure of penalty order received from GST authority.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1 Feb
-
Integrated Filing (Financial)
30 Jan - Submission of integrated financial results for Q3 2024.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 Jan - Approval of financial results and key appointments.
-
Board Meeting Outcome for Outcome Of Board Meeting
30 Jan - Approval of financial results and key appointments.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
Company has four centers situated at Hyderabad, Pune and Kolkata which offers services ranging from an blood test to a CT/MRI Scan. Investigations are broadly classified as Lab, Pathological, Radiology, Imageology, Cardiology and Gastroscopy. Other services include:
a) Master Health Check Up
b) Executive Health Check Up
c) Well Woman Check Up
d) Cardiac Profile
e) Diabetic Profile
f) Corporate Services
g) Home visits
h) Ambulance Services
i) Health Camps
Company is also expanding its services to Executives, Government Employees, Industrial workers etc., through various tie-ups.